Tag Archives: biosimilars

December, 2018

November, 2018

September, 2018

August, 2018

July, 2018

  • 23 July

    FDA Approves Pfizer’s Nivestym, a Biosimilar to Neupogen (filgrastim)

    NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE:PFE) today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved NIVESTYM™ (filgrastim-aafi), a biosimilar to Neupogen1 (filgrastim), for all eligible indications of the reference product. “The FDA approval of NIVESTYM marks an important step in helping expand access to critical treatment options …